Bayesian meta-analysis of penetrance for cancer risk
Biometrics · 27.03.2024 · 80 (2)
DOI: 10.1093/biomtc/ujae038 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Biometrics, online erschienen am 31.05.2024. Verfasst von Thanthirige Lakshika M Ruberu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX 75080, United States. Hauptthemen laut MEDLINE: Bayes Theorem, Genetic Predisposition to Disease, Penetrance. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Multi-gene panel testing allows many cancer susceptibility genes to be tested quickly at a lower cost making such testing accessible to a broader population. Thus, more patients carrying pathogenic germline mutations in various cancer-susceptibility genes are being identified. This creates a great opportunity, as well as an urgent need, to counsel these patients about appropriate risk-reducing management strategies. Counseling hinges on accurate estimates of age-specific risks of developing various cancers associated with mutations in a specific gene, ie, penetrance estimation. We propose a meta-analysis approach based on a Bayesian hierarchical random-effects model to obtain penetrance estimates by integrating studies reporting different types of risk measures (eg, penetrance, relative risk, odds ratio) while accounting for the associated uncertainties. After estimating posterior distributions of the parameters via a Markov chain Monte Carlo algorithm, we estimate penetrance and credible intervals. We investigate the proposed method and compare with an existing approach via simulations based on studies reporting risks for two moderate-risk breast cancer susceptibility genes, ATM and PALB2. Our proposed method is far superior in terms of coverage probability of credible intervals and mean square error of estimates. Finally, we apply our method to estimate the penetrance of breast cancer among carriers of pathogenic mutations in the ATM gene.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX 75080, United States.
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
- Department of Data Science, Dana Farber Cancer Institute, Boston, MA 02215, United States.
ORCID-Profile: Danielle Braun, Giovanni Parmigiani, Swati Biswas
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Ruberu, T. L. M., Braun, D., Parmigiani, G., & Biswas, S. (2024). Bayesian meta-analysis of penetrance for cancer risk. Biometrics, 80(2). https://doi.org/10.1093/biomtc/ujae038
Vancouver
Ruberu TLM, Braun D, Parmigiani G, Biswas S. Bayesian meta-analysis of penetrance for cancer risk. Biometrics. 2024;80(2). doi:10.1093/biomtc/ujae038
BibTeX
@article{Ruberu2024,
author = {Ruberu, Thanthirige Lakshika M and Braun, Danielle and Parmigiani, Giovanni and Biswas, Swati},
title = {Bayesian meta-analysis of penetrance for cancer risk},
journal = {Biometrics},
year = {2024},
volume = {80},
number = {2},
doi = {10.1093/biomtc/ujae038}
}
EUVIMED